Company ProfilePremium

Dycem

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Dycem - Semiconductor showcase

Year Founded & Workforce

1966

87 Employees

Industry

Semiconductor
Dycem logo

Dycem Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Dycem Overview

Dycem is a specialist British maker of polymeric contamination-control flooring. Its mats are made in Bristol from a high-tack polymer that pulls dirt off shoe soles and trolley wheels and holds it at the surface. Disposable peel-off "sticky mats" must be stripped layer by layer. A Dycem mat is washed in place and lasts three to five years. The company says its mats capture up to 99.9% of foot- and wheel-borne contamination and cut airborne particles by up to 75%. An antimicrobial additive (Biomaster) is built into the material, and the mats are static-dissipative. These properties matter in semiconductor fabs, aseptic pharmaceutical suites, medical-device plants and, increasingly, hyperscale and AI data centres. Dycem was a pioneer of reusable contamination-control mats in the 1970s. Today it serves more than 30,000 sites in over 50 countries, sells direct and through distributors, and sits under private-equity ownership with a lean, cash-generative financial profile.


What the company does. Dycem designs, makes and installs reusable floor-level contamination-control systems, and it sells a smaller range of non-slip products. The core material is a proprietary high-friction, high-tack polymer compound. Its surface energy lets it attract and hold particles (dust, fibres, skin flakes, microbes carried on footwear) without an adhesive layer. Dycem places mats at the points where contamination crosses into a controlled area: personnel airlocks, gowning rooms, material airlocks, corridor-to-cleanroom transitions, server-hall entrances and loading bays. Its argument is that most contamination enters a cleanroom at floor level. Capturing it there lowers the particle load on HVAC filtration and on downstream cleaning.

Business model. Dycem is a vertically integrated specialist manufacturer with a consultative selling model. All production is in Bristol, where it has been since 1966. A sale usually starts with a free site survey. Dycem's contamination-control specialists, or a distributor, map traffic flows and recommend mat sizes, formats and placement. Each system is then custom-cut and installed. After sale, Dycem offers an annual Particle Collection Efficiency Test (PCET) free of charge to confirm mat performance, plus cleaning guidance and replacement supply.

Revenue model. Revenue comes almost entirely from product sales: mats, flooring, bench mats, access tiles and non-slip goods. Installation and survey services are bundled in. There is no subscription or licensing income. Because a mat lasts three to five years, replacement demand is recurring but lumpy. Growth depends on new installations, new facilities (fab, pharma and data-centre construction) and converting sites away from disposable tacky mats. The mix between Contamination Control and Non-Slip is not publicly disclosed. Contamination Control has been the strategic focus since the 2002 re-branding.

Value-chain position. Dycem is a Tier-2 supplier of cleanroom consumables and fit-out products. It sells to facility owners, operators and contractors in semiconductor fabs, pharmaceutical plants and data centres, rather than supplying the process tools themselves. Its products are specified at the facility-design stage, often alongside wall and ceiling cladding, HVAC, and gowning protocols. They are also sold as retrofits through cleanroom-service companies and laboratory distributors such as Avantor/VWR.

Customer types and end-markets.

Semiconductor & electronics: Typical application: Fab gowning areas, sub-fab corridors, tool-move routes; static-dissipative performance; Relevance to Dycem: First target market for contamination-control mats in 1974; current activity includes SEMICON India 2026 and a pilot at NXP Semiconductors, Hamburg

Pharmaceutical & biotech: Typical application: GMP Grade A–D transitions, aseptic filling suites, gowning rooms; Relevance to Dycem: Core market; EU GMP Annex 1 emphasis on contamination-control strategies supports demand

Medical devices: Typical application: Cleanroom assembly; customer testimonials include Stryker, Getinge and Alcon; Relevance to Dycem: Core market

Optical: Typical application: Lens and coating cleanrooms (e.g., Hoya testimonial); Relevance to Dycem: Niche

Data centres: Typical application: Data-hall and server-room entrances; ESD-safe surfaces; Relevance to Dycem: Growth vertical since the 2020s; dedicated "Dycem Data Centers" brand

Aerospace & automotive: Typical application: Clean assembly, paint shops; Relevance to Dycem: Established

Food & beverage, cosmetics: Typical application: Hygiene zones; Relevance to Dycem: Entered 2010–2014

Nuclear: Typical application: Contamination transfer control; Relevance to Dycem: Entered 2010–2014; "Dycem Lite" positioned for nuclear and AI data centres

Healthcare & hospitals: Typical application: Infection prevention at floor level; Relevance to Dycem: Established (contamination control and non-slip)

Cannabis cultivation: Typical application: Cross-contamination control between grow rooms; Relevance to Dycem: Niche

Assistive living / occupational therapy: Typical application: Non-slip mats, rolls, jar openers; Relevance to Dycem: Non-Slip division

Company's own description. Dycem describes itself as a world-leading manufacturer of contamination-control mats and flooring, founded in 1966 and headquartered in Bristol. It emphasises effective, efficient and sustainable contamination control from the floor up, and reusable, antimicrobial mats that last three or more years.

Independent characterisation. Dycem is a niche category leader in reusable polymeric contamination-control flooring. It is a small company (turnover of about GBP 20 million in FY2024) whose brand recognition in regulated cleanroom markets far exceeds its scale. Its moat is a 50-year-old material formulation, a specification-led sales motion, and a sustainability argument against disposable sticky mats. It competes indirectly with much larger, diversified consumables suppliers (3M, ITW, Berkshire, Kimberly-Clark, Contec), whose peel-off mats remain the default choice in many fabs. Dycem has no direct peer of comparable focus.

Strategy

Stated strategic themes. Dycem's public messaging under the 60th-anniversary campaign and the "Dycem Difference" positioning centres on four themes:

  1. Effective contamination control: scientifically validated capture of up to 99.9% of foot- and wheel-borne contamination, backed by annual PCET performance testing.

  2. Efficiency: fewer cleaning interventions and lower particle loads on HVAC and filtration.

  3. Sustainability: reusable mats that replace daily stacks of disposable peel-off plastic sheets, framed as "a cleaner today and a greener tomorrow".

  4. Designing contamination out: specifying Dycem at the infrastructure design stage, together with partners such as Kleenclad (wall cladding), rather than treating mats as consumables.

Strategic initiatives (last 24 months).

Leadership reset: Timing: Apr 2025; Description: New CEO (Lyndon Wild) and a slimmed board, followed by headcount efficiency (87 average employees in FY2025 vs 92 in FY2024) and a sharp rise in profit

Data-centre vertical: Timing: 2024–2026; Description: Dedicated "Dycem Data Centers" brand; access tiles and Dycem Lite for AI data centres; DCD Connect London exhibition; marketing aimed at operators' 2027 budget cycles

Semiconductor push in India: Timing: 2026; Description: Kleenclad × Dycem joint presence at SEMICON India 2026 (17–19 Sep 2026, Hall 2, Booth H3618, Yashobhoomi, New Delhi) targeting India's new fab and OSAT projects

Nanofabrication and research cleanrooms: Timing: Jul 2025; Description: Sponsorship of NanofabUK 2025 at the University of Glasgow

European regulatory positioning: Timing: 2024–2026; Description: EVP Europe commentary on regulatory trends; participation in the Balkan Cleanroom Forum 2026; alignment with EU GMP Annex 1 contamination-control strategies

Distribution expansion: Timing: 2023–2026; Description: New partners in Israel (BioGate) and India (Kleenclad, which markets "KleenMats by Dycem")

Heritage and brand campaign: Timing: Jan 2026; Description: 60th-anniversary communications across pharma and cleanroom trade media

Refinancing: Timing: Feb 2025 and Apr 2026; Description: New secured charges registered, supporting the capital structure

Medium-term financial targets. Not publicly disclosed.

Products & Services

Contamination Control

ProductDescriptionKey specifications / capabilitiesTarget customer & usePricing indication
Dycem CleanZoneFlagship fixed, semi-permanent polymeric contamination-control mat or floorCaptures up to 99.9% of foot- and wheel-borne contamination and up to 75% of airborne particles; Biomaster antimicrobial built in for the product's life; 3–5+ year life; washable; custom sizes and colours; static-dissipative up to 10⁸ ohmsGowning rooms, personnel airlocks, material airlocks and cleanroom entrances in pharma, semiconductor and medical devicesQuoted per installation
Dycem WorkZoneHeavy-duty fixed mat for areas with heavy wheeled trafficThicker, harder-wearing formulation for trolleys, pallet trucks and wheelchairs; same capture mechanismWarehouses, material transfer routes, loading areas, hospital corridorsQuoted per installation
CleanZone Floating MatsLoose-lay, self-install matsLay over rough or uneven subfloors without professional installation; can be repositionedTemporary or changing layouts, high-traffic areas, leased facilitiesCatalogue items via distributors
CleanZone-FlexiFlexible-format matPositioned as a direct replacement for peel-off tacky mats; distributed in the US through Prudential Cleanroom ServicesUsers switching from disposable matsCatalogue
ProtectamatContamination-control floor-mat rangeDistributed through Avantor/VWR (e.g., part CC02/06/1, blue)Laboratories, light-duty cleanroomsCatalogue
Bench MatsFlexible work-surface matsGrip equipment on benches and trap surface contamination; e.g., 600 × 450 mm, black and green (part CZ06/BM60045)Laboratories, cleanroom work surfacesVWR list prices about GBP 463–528 or EUR 390–586 depending on country and colour
Access Tiles / access panelsModular tile formatSegment flooring and fit raised-floor environmentsData centresQuoted
Dycem LiteLighter-format reusable matLonger-lasting alternative to disposable mats that also reduces wasteNuclear facilities and AI data centresQuoted
Cleanroom rollers (historic)Tacky rollers for surface cleaningPart of the contamination-control range by 2000Cleanrooms—
ServiceDescription
Site surveyFree on-site consultation to map traffic and recommend placement and sizing
InstallationProfessional installation for fixed systems
Particle Collection Efficiency Test (PCET)Complimentary annual performance test on installed mats
Hygiene and efficiency testingIndependent measurement offered with partners (e.g., basan in Germany)
Cleaning protocolsGuidance plus compatible cleaning tools (e.g., Contec PowerMop CE)

Services attached to the product.

Non-Slip

ProductDescriptionSpecificationsTarget customer
Non-slip material rollCut-to-size sheet that grips on both sides without adhesive0.4 mm thick; rolls such as 8 in × 6.5 ft, 16 in × 6.5 ft, 8 in × 10 yd; red, blue, yellowOccupational therapy, special-needs education, home use (US retail through School Specialty, about USD 105–315)
Non-slip place and dining matsStabilise plates, bowls and chopping boardsWashable, latex-free, non-toxic, antimicrobialPeople with stroke, arthritis or reduced grip; care homes
Non-slip floor matsFirmer footing for transfers and sit-to-standYellow range for visual cuesPhysiotherapy, elderly care
Jar and bottle openersGrip aidsRelaunched 1998Consumers with reduced hand strength
Non-slip wipesAlcohol-based restoring wipesRestore grip instantlyAll non-slip users

Financial Narrative

Dycem Limited files full group accounts with Companies House. Figures below are in GBP millions from the filed statutory accounts for each year ended 31 December. The company does not publish gross profit, operating profit, EBITDA, EPS or cash-flow statement figures outside its statutory accounts, and those line items are not publicly disclosed in summary form. As a private company, it has no EPS or per-share dividend metrics.

Revenue

FY2022 and FY2025 turnover are not publicly disclosed in summary form. The FY2025 group accounts were filed on 31 July 2026. The FY2023 figure is derived from the FY2024 accounts, which report a GBP 1.44 million (8%) increase to GBP 19.81 million. Turnover grew at a compound annual rate of about 13.4% between FY2020 and FY2024, from GBP 11.97 million to GBP 19.81 million. Growth between FY2021 and FY2023 was about 13.0% a year. (The two zeros in the growth row stand for years with no prior-year comparison, not for flat growth.)

Profitability

The FY2024 net margin was about 12.7% (GBP 2.52 million profit on GBP 19.81 million turnover). Profit for FY2025 rose 81% to GBP 4.55 million. Even if turnover had grown at the high end of the historical range, net margin would have exceeded 20%, which suggests strong operating leverage, a non-recurring gain, or both. Because the FY2025 turnover figure is not publicly disclosed, a precise FY2025 margin cannot be stated. Gross, operating and EBITDA margins are not publicly disclosed.

Ratios

Asset turnover in FY2024 was about 2.15x (turnover over average total assets). Revenue per employee was about GBP 215,000 (GBP 19.81 million over 92 employees). Goodwill and intangibles, working-capital components, the split between short- and long-term debt, interest cover, ROIC and the cash conversion cycle are not publicly disclosed in summary form.

Commentary

Growth. Turnover rose about 65% between FY2020 and FY2024. The FY2021 rebound of 20% followed pandemic disruption to site access and facility projects in FY2020. Growth then continued at double-digit rates as semiconductor fab construction, pharmaceutical capacity investment and data-centre build-outs gathered pace. Growth slowed to about 8% in FY2024, in line with a broader post-boom normalisation in cleanroom capital spending.

Profitability and leverage. Profit almost doubled in FY2025 while headcount fell from 92 to 87. This points to a leaner operating model under the new leadership team installed in April 2025, combined with the fixed-cost leverage of a single-site manufacturing operation. Per-employee productivity is high for a manufacturer, reflecting a high-value, low-volume polymer product sold through a consultative channel.

Capital allocation. Net assets have not risen in step with profit, which is typical of a private-equity-owned business. Net assets fell from GBP 6.49 million (FY2020) to GBP 3.34 million (FY2021) even as turnover grew 20%, which is consistent with a significant distribution or reorganisation of intra-group balances in FY2021. In FY2025, profit of GBP 4.55 million was accompanied by only a GBP 0.20 million rise in net assets. That implies distributions to the parent or other reserve movements of about GBP 4.3 million in the year. Secured charges were renewed in February 2025 and again in April 2026, which indicates that group financing (probably bank facilities at the holding-company level) was refinanced or extended. Facility amounts, maturities and pricing are not publicly disclosed.

Liquidity. Cash rose for three straight years, from GBP 0.25 million (FY2022) to GBP 2.93 million (FY2025). Total liabilities are modest, at under a quarter of total assets. The operating company carries a conservative balance sheet, with any acquisition leverage held higher in the Seafox structure.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Key Financials and Margin Analysis (%)

MetricFY2020FY2021FY2023FY2024

Turnover (GBP Mn)

11.9714.3918.3719.81

YoY growth (%)

020.207.8

Key Financials and Margin Analysis (%) (FY2024–FY2025)

MetricFY2024FY2025

Profit for the financial year (GBP Mn)

2.524.55

YoY growth in profit (%)

080.8

Key Financials

MetricFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Net assets / shareholders' funds (GBP Mn)

4.285.206.493.343.725.768.278.47

Cash at bank (GBP Mn)

0.290.231.710.770.251.151.722.93

Balance Sheet

MetricFY2023FY2024FY2025

Total assets (GBP Mn)

7.7510.6811.03

Total liabilities (GBP Mn)

1.992.422.56

Net assets (GBP Mn)

5.768.278.47

Liabilities as % of total assets

25.722.723.2

Cash as % of total assets

14.816.126.6

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2024FY2025

Return on average equity (%)

35.954.4

Return on average total assets (%)

27.341.9

Total liabilities / equity (x)

0.290.30

Financial Analysis

MetricFY2023FY2024FY2025

Average employees (group)

959287

Region Overview

RegionPresenceDemand driversDirection

UK & Ireland

Bristol HQ, manufacturing, direct sales; Irish healthcare distribution (John Preston)

Pharma, NHS healthcare, nanofabrication (e.g., Glasgow JWNC), data centres around London

Stable to growing

Continental Europe

Dycem Europe GmbH (Rastatt, Germany); EVP Sales Europe; trade shows such as Lounges (Karlsruhe), EPHJ (Geneva), Balkan Cleanroom Forum

EU GMP Annex 1 contamination-control strategies, semiconductor (e.g., NXP Hamburg), medical devices (Switzerland)

Growing

North America

Dycem Corporation (Smithfield, RI); office in The Woodlands, TX; distributors such as Prudential Cleanroom Services, Avantor/VWR, School Specialty

CHIPS Act fab construction, biologics capacity, hyperscale data centres

Growing; largest data-centre opportunity

Asia-Pacific

Philippines regional office since 2013; Kleenclad partnership in India

Semiconductor and electronics assembly (Philippines, Malaysia, India), pharma (India)

Fastest-growing potential, especially India's semiconductor programme

Middle East

BioGate distribution in Israel since 2023

Life sciences, diagnostics, semiconductor (Israel)

Emerging

Capital Markets

ItemPosition

Ownership

Longacre Group, through Seafox Dycem 1 and 2 Limited, since February 2016

Funding type

Leveraged buyout; secured debt facilities

Secured charges outstanding

Charges registered 28 Feb 2025 and 23 Apr 2026 (032394390003 and 032394390004); 032394390002 satisfied 6 Mar 2025

Dividend policy

Not publicly disclosed. Upstream distributions are implied by the gap between profit and the movement in net assets (about GBP 4.3 million in FY2025).

Analyst Conclusions

Management guidance. Not publicly disclosed. Messaging points to growth in semiconductors (especially India), data centres, and pharma compliance under EU GMP Annex 1.

Growth expectations. Over the cycle, Dycem's growth should track cleanroom construction and conversion from disposable mats: a high single-digit to low double-digit base rate, consistent with the 13.4% compound rate from FY2020 to FY2024 and 7.8% in FY2024.

Bull case.

  1. Profit inflection is durable. FY2025 profit rose 81% to GBP 4.55 million on lower headcount (87). If the April 2025 leadership reset has structurally lifted margins, Dycem is a high-return, cash-generative asset with return on equity above 50%.

  2. Multiple structural tailwinds at once. Fabs (US, EU, India), AI data centres and Annex 1 pharma upgrades all require floor-level contamination control. Dycem has dedicated go-to-market efforts in each: SEMICON India 2026, the Dycem Data Centers brand, and its European sales leadership.

  3. Sustainability conversion. As customers seek to reduce single-use plastics, Dycem's reusable mats can win share from a much larger disposable installed base.

Bear case.

  1. Scale disadvantage. At about GBP 20 million in turnover, Dycem faces 3M, ITW and Berkshire, which can bundle mats with wipes, garments and gloves, and many fab procurement teams default to disposables.

  2. Cash extraction limits reinvestment. About GBP 4.3 million of implied FY2025 distributions and repeated secured refinancings suggest the business is run for yield, not capacity expansion. A single Bristol plant is a concentration risk.

  3. Cyclicality and trade friction. Semiconductor and pharma capex pauses, US tariff volatility on UK exports, and a shrinking headcount could stall the top line, as the slowdown to 8% growth in FY2024 already showed.

Key catalysts (next 12 months):

Conversion of SEMICON India 2026 leads: Expected timing: H1 2027; Watch for: Fab and OSAT orders through Kleenclad

Data-centre orders funded from 2027 budgets: Expected timing: 2027; Watch for: Hyperscale or colocation framework agreements

FY2026 group accounts: Expected timing: Due by 30 Sep 2027; Watch for: Turnover growth, margin sustainability, distributions

Possible ownership change: Expected timing: Any time; Watch for: Longacre exit through trade sale or secondary buyout after 10+ years

New product formats: Expected timing: 2026–2027; Watch for: Extension of Dycem Lite and Access Tiles

Refinancing terms: Expected timing: Ongoing; Watch for: Further charges or satisfactions at Companies House

Analyst verdict. Dycem is a small company with an outsized reputation. Sixty years after its founding, it remains the reference brand for reusable polymeric contamination-control flooring, a niche it created in 1974 and still defines. The investment case rests on a simple proposition. Contamination enters controlled environments at floor level, and a mat that captures it for three to five years beats a disposable sheet replaced every day, on performance, cost of ownership and waste.

The financial record supports the proposition. Turnover rose from GBP 11.97 million in FY2020 to GBP 19.81 million in FY2024. Profit reached GBP 4.55 million in FY2025, the strongest year on record, and cash reached GBP 2.93 million. The April 2025 management reset under CEO Lyndon Wild coincided with a step change in profitability and a leaner workforce. That suggests operational discipline, though it should be confirmed by FY2026 results before being called structural.

The strategic map is sound. India's semiconductor build-out, AI data-centre construction and the EU's tighter GMP regime all play to Dycem's strengths, and the company has placed specific bets in each through partnerships, a dedicated data-centre brand and a visible trade-show presence.

The constraints are equally clear. Dycem is a sub-GBP 25 million business with one plant, a thinning field force and an owner that has been extracting cash for a decade. It competes against conglomerates whose disposable mats are embedded in fab procurement. Without reinvestment in capacity, regional technical sales and validation data, the reusable category may stay a premium niche rather than becoming the industry standard.

On balance, Dycem is a high-quality, cash-generative niche asset at an inflection point. The next 12–24 months, including a probable ownership transition, will show whether it scales into the semiconductor and data-centre cycle or stays a profitable specialist.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedBackground

Lyndon John Wild

Director; Chief Executive Officer

1 Apr 2025

Previously Global Head of Project & Program Management at DCC Vital; Head of Product Innovation at ThermoSafe; earlier managing-director roles. Also a director of Seafox Dycem 1 Limited.

Curtis John James

Director; Finance Director; Company Secretary

1 Aug 2024

Group finance lead; also a director of Seafox Warwick 1 Limited

Iain Henry Abrahams

Director

13 Jan 2016

Longacre-era appointee present since the acquisition; sits across the Seafox Dycem and Seafox Warwick holding companies

Stanislaus Eduard (Stani) Schmidt-Chiari

Director

13 Jan 2016

Co-founder and partner of Longacre Group; formerly H.I.G. Capital Europe; also linked to Pyroban Group and Longacre Group International

Executive Leadership Team

NameRole

Stewart Hyde

Executive Vice President of Sales – Europe

Carlos Mourelle

Data-centre business development (Dycem Data Centers)

Jhun Yparraguirre

Sales Manager, Asia Region (appointed to lead the Philippines office at its 2013 opening)

Board & Management Changes

DateChangeContext

1 May 2023

Nick David Crofts appointed director

Ceased 18 Jan 2024

18 Jan 2024

Joseph Richard Hainsworth Barry appointed director

Also linked to Seafox Dycem holding companies; ceased 31 Mar 2025

31 Jul 2024

Monica Jane Briand ceased as director and company secretary

Succeeded by Curtis John James

1 Aug 2024

Curtis John James appointed director and company secretary

New finance lead

31 Mar 2025

Mark Dalziel ceased as director

Long-serving Managing Director (in role by 2013)

31 Mar 2025

Stewart George Cantley ceased as director

—

31 Mar 2025

George Elliott Nicholson ceased as director

Longacre co-founder steps off the operating board

31 Mar 2025

Joseph Barry ceased as director

—

1 Apr 2025

Lyndon John Wild appointed director (CEO)

Leadership transition; streamlined board

Major Shareholders

HolderStakeBasis

Longacre Group (through Seafox Dycem 1 Limited and Seafox Dycem 2 Limited)

Controlling (single corporate shareholder of Dycem Limited)

Longacre acquisition announcement, 15 Feb 2016; Companies House register (one shareholder, one person with significant control)

Competitive Landscape

Key Competitors

CompetitorHQOwnershipCompeting offerPositioning vs Dycem

3M

USA

Listed (NYSE: MMM)

Disposable Nomad and clean-walk mats

Scale, brand and distribution; disposable format

ITW Contamination Control (incl. Texwipe)

USA / Netherlands

Listed parent (NYSE: ITW)

Tacky mats, cleanroom wipers and consumables

Broad cleanroom portfolio; strong in semiconductor

Berkshire Corporation

USA

Private

Disposable tacky mats, wipers

Strong US semiconductor relationships

Liberty Industries

USA (East Berlin, CT)

Private

US-made tacky mats, tacky rollers

Price-competitive disposable supplier

Terra Universal

USA

Private

Sticky mats, cleanroom furniture and modular cleanrooms

One-stop cleanroom fit-out

Contec

USA

Private

Cleanroom consumables; adhesive pads

Also a complementary partner (cleaning tools)

Kimberly-Clark Professional

USA

Listed parent (NYSE: KMB)

Cleanroom apparel and consumables

Disposable consumables ecosystem

Micronclean (CES)

UK

Private

Cleanroom laundry, consumables, sticky mats

UK cleanroom-service competitor

Kleen-Tex

Germany / USA

Private

Entrance and contamination-control mats

Entrance-matting specialist

High-Tech Conversions (Hospeco Brands Group)

USA

Private

Tacky mats, cleanroom paper

Disposable consumables

Valutek

USA

Private

Cleanroom consumables, sticky mats

Distributor-led

Superior Cleanroom Products, Wearwell, Scapa

USA / UK

Various

Sticky mats, adhesive films, matting

Fragmented tail

Peer Comparison FY2025

AttributeDycem3MITW Contamination ControlBerkshire

Mat technology

Reusable polymeric

Disposable peel-off

Disposable peel-off

Disposable peel-off

Mat life

3–5+ years

Layer changed daily

Layer changed daily

Layer changed daily

Antimicrobial built in

Yes (Biomaster)

Product-dependent

Product-dependent

Product-dependent

Focus

Floor-level contamination-control specialist

Diversified conglomerate

Broad cleanroom consumables

Cleanroom consumables

Ownership

Private equity (Longacre)

Public

Public parent

Private

Recent Developments

There have been no announced layoffs, litigation, product recalls or regulatory actions in the period. --

Company Snapshot

87

Employees

1966

Founded

Bristol, United Kingdom

Headquarters

SWOT Analysis

Strengths

  • Category pioneer: first contamination-control mats in 1974, with 50+ years of formulation know-how.
  • Installed base of over 30,000 sites in more than 50 countries.
  • Strong profitability: FY2025 profit of GBP 4.55 million, up 81%; return on average equity of about 54%.
  • Low balance-sheet risk at the operating level: liabilities about 23% of total assets, and cash up to GBP 2.93 million in FY2025.
  • Differentiated product claims: up to 99.9% capture, up to 75% airborne reduction, built-in Biomaster antimicrobial, static-dissipative to 10⁸ ohms.
  • Blue-chip medtech and pharma references (Stryker, Getinge, Alcon, Hoya) and a semiconductor pilot at NXP Hamburg.

Weaknesses

  • Small scale: FY2024 turnover of GBP 19.81 million against diversified competitors.
  • Single manufacturing site in Bristol, which concentrates operational and supply risk.
  • Declining headcount (95 in FY2023 to 87 in FY2025), which may constrain field sales coverage.
  • Revenue growth slowed to about 8% in FY2024 from double digits.
  • Heavy distribution of profits upstream (about GBP 4.3 million implied in FY2025) limits reinvestment capacity.
  • No disclosed patent protection; the moat rests on know-how and brand.

Opportunities

  • India's semiconductor programme, addressed through the Kleenclad partnership at SEMICON India 2026.
  • AI data-centre construction, addressed through the Dycem Data Centers brand, Access Tiles and Dycem Lite.
  • EU GMP Annex 1 compliance programmes in pharma.
  • Sustainability-driven conversion of disposable sticky-mat users.
  • Advanced therapies and biologics capacity (e.g., Touchlight).
  • Nuclear decommissioning and new-build programmes (Dycem Lite).

Threats

  • Price competition from 3M, ITW, Berkshire and low-cost converters.
  • Cyclicality of semiconductor and pharma capital spending.
  • US tariff and trade-policy changes affecting UK-made exports to Dycem Corporation.
  • Private-equity exit risk: ownership change after more than ten years under Longacre could shift strategy.
  • Rising polymer and additive input costs.
  • Refinancing risk at the holding-company level (secured charges renewed in 2025 and 2026).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
18–23 Dec 2024EVP Sales Europe Stewart Hyde interviewed by Medical Technology Insights on cleanroom products and 2025 regulatory trendsPositions CleanZone, WorkZone and Floating Mats as the main lines; highlights sustainability against sticky mats
28 Feb 2025New secured charge 032394390003 createdRefinancing of group debt
6 Mar 2025Prior charge 032394390002 satisfied in fullCompletes the refinancing
31 Mar 2025Directors Mark Dalziel, Stewart Cantley, Elliott Nicholson and Joseph Barry step downEnd of the long-standing management era
1 Apr 2025Lyndon Wild appointed director and CEONew leadership with an operations and product-innovation background
10 Jun 2025FY2024 group accounts filed: turnover GBP 19.81 million (+8%), profit GBP 2.52 millionSteady growth; net assets up 43%
22 Jul 2025Sponsor of NanofabUK 2025 (University of Glasgow)Visibility in UK semiconductor and nanofabrication research
11 Aug 2025CEO's registered details updatedAdministrative
18 Aug 2025Confirmation statement with no changesStable ownership
Sep 2025Dycem Data Centre stand at DCD Connect LondonPush into the data-centre vertical
14 Jan 2026Pharmaceutical Technology article marks Dycem's 60th anniversaryBrand heritage campaign; over 50 countries and 30,000 sites cited
20 Jan 2026Cleanroom Technology covers the 60-year milestoneReinforces market-pioneer positioning
28 Feb 2026Finance Director's registered details updatedAdministrative
23 Apr 2026New secured charge 032394390004 created (registered 7 May 2026)Further financing arrangement
2026CleanZone mat installed in the primary change lobby at Touchlight (DNA manufacturing)Advanced-therapy and biotech reference installation
2026Participation in the Balkan Cleanroom Forum 2026Expansion in South-East European pharma
31 Jul 2026FY2025 group accounts filed: profit GBP 4.55 million (+81%), net assets GBP 8.47 million, cash GBP 2.93 million, 87 employeesStrongest profit in the available record
18 Aug 2026Confirmation statement with no changesOwnership unchanged
17–19 Sep 2026Kleenclad × Dycem exhibit at SEMICON India 2026, New DelhiDirect targeting of India's semiconductor fab build-out
H2 2026Data-centre marketing targets operators' 2027 capital budgetsPipeline building in AI data centres

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Income Statement

3 charts
Key Financials (FY2020–FY2024): Turnover rose from GBP 12 Mn in FY2020 to GBP 19.8 Mn in FY2024.
Dycem — Key Financials (FY2020–FY2024)
Series (GBP Mn)FY2020FY2021FY2023FY2024
Turnover1214.418.419.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

  1. Companies House, Dycem Limited (03239439): filing history, officers, charges and group accounts FY2022–FY2025 (find-and-update.company-information.service.gov.uk)
  2. Companies House, Dycem.com Limited (00893039) name history (pay.company-information.service.gov.uk)
  3. Companies in the UK, Dycem Limited financial summary FY2018–FY2025 (companiesintheuk.co.uk)
  4. Endole, Dycem Limited and Seafox Dycem 1 Limited (open.endole.co.uk)
  5. Longacre Group, "Longacre Group Announces Acquisition of Dycem", 15 Feb 2016 (longacre.com)
  6. Pharmaceutical Technology, "Dycem Celebrates 60 Years of Contamination Control", 14 Jan 2026 (pharmtech.com)
  7. Cleanroom Technology, "Dycem marks 60 years of innovation in contamination control", 20 Jan 2026 (cleanroomtechnology.com)
  8. Manufacturing Chemist, "Dycem opens office in Asia", 9 Apr 2013 (manufacturingchemist.com)
  9. Cleanroom Technology, "Dycem Contamination Control chooses Israeli cleanroom mat distributor", 6 Jun 2023 (cleanroomtechnology.com)
  10. Medical Technology Insights, Dycem EVP interview, Dec 2024 (med-technews.com)
  11. University of Glasgow, NanofabUK 2025 sponsor profile, 22 Jul 2025 (gla.ac.uk)
  12. DatacenterDynamics, Dycem Data Centers company page (datacenterdynamics.com)
  13. Kleenclad, KleenMats by Dycem (kleenclad.com)
  14. Pharmaceutical Online, Dycem company profile, May 2000 (pharmaceuticalonline.com)
  15. Reinraum.de, NXP Semiconductors Hamburg pilot (reinraum.de)
  16. Medical Device Network, Dycem contact and offices (medicaldevice-network.com)
  17. Avantor/VWR product listings for Dycem (b2b-uk.vwr.com)
  18. IndexBox, tacky entry mats market outlook (indexbox.io)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.